SLQT vs EHC

For growth investors, SelectQuote, Inc.

(SLQT) is the stronger pick with 15. 5% revenue growth year-over-year, versus 10. 5% for Encompass Health Corporation (EHC). Encompass Health Corporation (EHC) offers the better valuation at 19. 0x trailing P/E (17. 7x forward), making it the more compelling value choice. Analysts rate Encompass Health Corporation (EHC) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Encompass Health Corporation (EHC) is the cheapest at 19.

0x versus SelectQuote, Inc. at 90. 2x.

Over the past 5 years, Encompass Health Corporation (EHC) delivered a total return of +60.

0%, compared to -95. 9% for SelectQuote, Inc. (SLQT). Over 10 years, the gap is even starker: EHC returned +246. 0% versus SLQT's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Encompass Health Corporation (EHC) is the lower-risk stock at 0.

40β versus SelectQuote, Inc. 's 1. 96β — meaning SLQT is approximately 386% more volatile than EHC relative to the S&P 500. On balance sheet safety, SelectQuote, Inc. (SLQT) carries a lower debt/equity ratio of 72% versus 83% for Encompass Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), SelectQuote, Inc.

(SLQT) is pulling ahead at 15. 5% versus 10. 5% for Encompass Health Corporation (EHC). On earnings-per-share growth, the picture is similar: SelectQuote, Inc. grew EPS 106. 7% year-over-year, compared to 24. 2% for Encompass Health Corporation. Over a 3-year CAGR, SLQT leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Encompass Health Corporation (EHC) is the more profitable company, earning 9.

5% net margin versus 3. 1% for SelectQuote, Inc. — meaning it keeps 9. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHC leads at 17. 7% versus 4. 5% for SLQT. At the gross margin level — before operating expenses — EHC leads at 95. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SLQT: 233.

3% to $4. 00.

In this comparison, EHC (0.

7% yield) pays a dividend. SLQT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Encompass Health Corporation (EHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

40), 0. 7% yield, +246. 0% 10Y return). SelectQuote, Inc. (SLQT) carries a higher beta of 1. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EHC: +246. 0%, SLQT: -95. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SLQT (Financial Services) and EHC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SLQT is a small-cap high-growth stock; EHC is a mid-cap quality compounder stock. EHC pays a dividend while SLQT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.